Indica
Backed by cutting edge technology, an uncompromising focus on ease-of-use and dedicated customer service, Indica Labs’ software and services are being used to make vital discoveries in pathology labs and research organizations around the world.

Press Releases Tag

Indica Labs / Posts tagged "Press Releases"

Press Release: Indica Labs earns Work/Life Flexibility award and is named a Top Workplace by The Albuquerque Journal for the second year running

Albuquerque, NM, 2 September, 2021 – Indica Labs, a leading provider of computational pathology software, is proud to announce that they have been awarded a Top Workplaces™ honor by The Albuquerque Journal for a second year in a row.  In addition to being a Top Workplace, Indica Labs was the sole recipient of the Life/Work Flexibility award for 2021....

Press Release: Nottingham University Hospitals NHS Trust selects Indica Labs to deliver their Digital Pathology Solution with HALO AP

Albuquerque, NM, USA and Nottingham, UK, 1 July, 2021 – Following a formal tender process, Nottingham University Hospitals (NUH) NHS Trust today announced the selection of Indica Labs to aid in full digitisation of the pathology workflow. Indica Labs will deliver its leading digital pathology software, HALO AP®, fully integrated with existing hospital systems, alongside multiple Hamamatsu Nanozoomer scanners....

Press Release: Indica Labs and Ibex Partner to Deliver AI-powered Clinical Workflows for Digital Pathology

ALBUQUERQUE, NM and TEL AVIV, Israel – May 20, 2021 – Indica Labs, an industry leader in quantitative digital pathology & image management solutions, and Ibex Medical Analytics, a pioneer in artificial intelligence (AI) based cancer diagnostics, announced an agreement to integrate the Galen™ AI-based cancer diagnostics platform into the HALO AP® digital pathology workflow platform....

Press Release: Indica Labs announce integration of Philips iSyntax image format across all HALO® software platforms

Albuquerque, NM– October 22, 2020 – Indica Labs, a leading provider of computational pathology software and services, is pleased to announce integration of the Philips iSyntax image format into the full range of HALO® software platforms. This includes HALO AP for case-based image management and quantitative workflows, HALO Link for research image management and collaboration, HALO for image analysis, and HALO AI for AI-based tissue classification....

Press Release: Indica Labs announces launch of enterprise-wide, cloud-based digital pathology deployment at NCI

Albuquerque, NM – October 8, 2020 – Indica Labs, a leading provider of computational pathology software and services, are pleased to announce the formal launch of an enterprise-wide, cloud-based deployment of Indica Labs’ software within the National Cancer Institute (NCI), including HALO®, HALO AI, HALO Link and HALO AP. Accessible to hundreds of users within the NCI, managing millions of digital images, and facilitating the analysis of thousands of images daily, this is the largest single deployment of Indica Labs’...

Press Release: Indica Labs named a 2020 Top Workplace by The Albuquerque Journal

Albuquerque, NM – August 6, 2020 – Indica Labs, a leading provider of computational pathology software, is pleased to announce that they have been awarded a 2020 Top Workplaces™ honor by The Albuquerque Journal.  Indica Labs was the highest ranking company in the life sciences sector to be included in The Journal’s published list of Top Workplaces this year....

Press Release: OracleBio integrates Indica Labs HALO AI™ to enhance Digital Pathology Software Capabilities

July 9, 2020 | by Hannah Thomson OracleBio continues to enhance its digital pathology software capabilities by integrating Indica Labs HALO AI™ into its image analysis workflow. This latest step in OracleBio’s development will enable the quantitative digital pathology services provider to meet increasing demand from Pharmaceutical clients globally. The deep learning add-on, produced by Indica Labs, comes with six distinct neural networks for classification and segmentation of tissue and nuclei, as well as a python plugin for integration of custom neural networks....

Press Release: Indica Labs, Octo and Axle work with NIH to launch a global COVID-19 digital pathology repository

Albuquerque, NM and Reston, VA– May 21, 2020 – Indica Labs, a leading provider of computational pathology software, and Octo, a premiere information technology systems provider to the U.S. Federal Government, are pleased to announce the online COVID Digital Pathology Repository (COVID-DPR), a virtual collection of high resolution microscopic COVID-related human tissue images hosted at the National Institutes of Health....

Press Release: NeoGenomics Integrates HALO® From Indica Labs

Ft. Myers, Florida - March 31, 2020 - NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused testing services, today announced that it has integrated Indica Labs enterprise-level HALO AP™ image analysis platform for Image Analysis, Immunohistochemistry (IHC) and Multiplexing across its Clinical Services and Pharma Services businesses. The platform’s robust workflow modules streamlines analysis algorithms and provides rapid, quantitative results for a multitude of tissue types....

Press Release: Indica Labs completes nationwide deployment of HALO AP™ at NeoGenomics Laboratories, Inc.

Albuquerque, NM (April 3, 2020) – Indica Labs, the leading provider of computational pathology software, is pleased to announce the formal release of its HALO AP™ Anatomic Pathology platform at NeoGenomics Laboratories, Inc. HALO AP™ was developed by Indica Labs to address the needs of Anatomic Pathology labs. Offering a full range of tissue-based assays and workflows, the platform can be fully integrated within existing LIS solutions or can operate as a standalone case management system. HALO AP adds support for...

Press Release: Corista and Indica Labs Announce Integration to Advance Digital Pathology Workflows

Integrating the two platforms provides pathologists instant access to quantitative image analysis right from Corista’s digital pathology workflow suite Concord, MA (February 11, 2020) – Corista, an integrated pathology solutions leader, and Indica Labs, a leading provider of image analysis and management software, today announced their integrated capabilities. Through this integration, pathology labs gain the speed and flexibility to access Indica Labs’ HALO® image analytics directly from Corista’s award-winning DP3® comprehensive workflow suite. Corista’s DP3 is the digital pathology platform of choice...

Press Release: Indica Labs celebrates opening of new facility in Albuquerque, New Mexico

ALBUQUERQUE, NM USA - Indica Labs, an industry leader in quantitative digital pathology, held a ribbon cutting ceremony at its new facility on Friday, May 10, 2019. The ceremony was attended by Indica Labs employees, investors, local business leaders and government officials, including Bernalillo County Manager, Julie Morgas Baca, and Albuquerque Mayor, Tim Keller. The new facility allows Indica room to expand its workforce and relocate its headquarters to accommodate the company’s continued growth. Indica Labs has experienced year-over-year growth of...

Press Release: IONpath and Indica Labs establish a co-marketing agreement to promote spatially resolved analysis of tissues imaged with the Multiplexed Ion Beam Imaging (MIBI) System

USA 04/26/2019 – Indica Labs and IONpath announced today that a co-marketing agreement has been established to jointly promote their respective technologies for tissue-based, multiplexed biomarker research. IONpath’sTM MIBIscope™ platform uses secondary ion mass spectrometry (SIMS) to image antibodies tagged with monoisotopic metal reporters, permitting simultaneous visualization of 40+ markers in any tissue type, including FFPE, with unmatched resolution and sensitivity. “With capacity to measure dozens of proteins with sub-cellular resolution, the MIBIscope platform provides scientists with new insights in understanding cell...

Press Release: Fluidigm Announces Co-Marketing Agreement with Indica Labs to Offer Platform for Imaging Mass Cytometry Data Analysis to Aid Novel Digital Pathology Investigations

SOUTH SAN FRANCISCO, Calif., Feb. 07, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ: FLDM) and Indica Labs, Inc., today announced a co-marketing relationship for scalable and simple-to-use tissue image analysis for Imaging Mass Cytometry™ (IMC™). Under the terms of the agreement, Fluidigm and Indica Labs will cooperatively promote the next-generation digital pathology image analysis and image management platforms HALO®, HALO AI™ and HALO Link™ in conjunction with the Fluidigm® Hyperion™ Imaging System, MCD™ Viewer software and related Maxpar® antibodies and kits. “We are excited to announce this important relationship with Fluidigm,” said...

Press Release: New Mexico Governor Susana Martinez Announces Expansion of Pathology Software Company – Indica Labs Will Create Up To 58 New Jobs

Albuquerque, N.M. - Today, Governor Susana Martinez announced that Indica Labs, a homegrown technology company, will create up to 58 new jobs and invest more than $3 million in its new headquarters location in Albuquerque. The expansion is being supported by New Mexico's closing fund, LEDA. "We’re proud to see another great employer expand in New Mexico as we continue to grow our thriving science and technology sector," said Governor Martinez. "It's incredible to see our reforms working to help in...

Press Release: New paradigms for quantitative assessment of PD-1 and PD-L1 using the HALO® image analysis platform described in two recent publications

New Mexico, USA 21/6/2018 – Indica Labs, Inc announced today that the HALO® platform was used in two recent research papers that describe novel digital image analysis protocols for PD-1 and PD-L1 quantification and may help to identify potential responders to PD1/PD-L1 targeted immunotherapy in non-small cell lung cancer and melanoma. In the first study published in Nature Medicine this month, PD-1+ tumor-infiltrating lymphocytes (TILs) from non-small cell lung cancer (NSCLC) were subdivided into groups based on PD-1 expression and characterized...

The Netherlands Cancer Institute selects the HALOTM image analysis platform to expand its immuno-oncology research capabilities

Corrales, NM – October 24, 2017 – Indica Labs, the leading provider of software for quantitative evaluation of digital pathology images, is pleased to announce selection of the HALO image analysis platform by the Netherlands Cancer Institute (NKI) for in situ analysis of multiplexed biomarkers in tumor tissues. NKI will be using the HALO platform to analyze images captured from their Perkin Elmer Vectra® 3 multispectral imaging system.   Together with the Perkin Elmer OpalTM 7 reagent kits, this system allows simultaneous...

University of Cambridge Laboratories select HALO AITM deep learning technology to advance metabolic disease research

Corrales, NM - October 5, 2017 - Indica Labs Inc headquartered in Corrales, New Mexico, is pleased to announce the selection of the newly developed deep learning classification tool, HALO AITM, by the University of Cambridge Metabolic Research Laboratories (MRL) in England. HALO AI or ‘Artificial intelligence’ is a convolutional neural network platform resulting from years of effort by the Indica Labs’ research & development team, whose goal was to build a deep learning tool that could decipher and assess the...

MolecularMD Announces Partnership with Indica Labs to Support Improved Clinical Trial Histopathology Workflows Integrating Digital Biomarker Analysis Services

Portland, OR – September 29, 2017 – MolecularMD, a provider of molecular and tissuebased clinical trial assays and diagnostics for oncology based drug development programs, has announced a partnership agreement with Indica Labs, a leader in digital pathology imaging tools and services. The collaboration between the companies leverages MolecularMD’s diagnostic clinical testing solutions with Indica Labs’ digital biomarker analysis services to enable an efficient transition of pre-clinical research to the diagnostic setting and deployment of advanced image analysis workflows. Mindful...

Indica Labs Appoints a Vice President, Pharma Services

Dr. Keith J. Kaplan | July 31, 2017  | Source: Indica Labs Indica Labs announced today that Douglas Bowman has been appointed Vice President, Pharma Services. Mr. Bowman will play an important role as the company develops its image analysis and biomarker assay services business to support preclinical and clinical biomarker assays for Indica Lab’s academic, biotech, and pharma customers. Doug was previously at Takeda Pharmaceuticals for 11 years where he was responsible for developing quantitative biomarker assays to support the Oncology...

HALO® Deep Learning Technology Awarded for Automated Breast Cancer Metastasis Staging

Corrales, NM - April 24th 2017 - Indica Labs proudly announces its breakthrough HALO® Deep Learning technology excelled in the CameLyon17 diagnostic image analysis competition.  The international challenge engaged commercial and academic teams worldwide to develop deep-learning algorithms to analyze 500 whole-slide H&E lymph node images and calculate TNM staging of 100 breast cancer patients. The HALO Deep Learning solution was the highest ranking commercial solution and third overall among 32 accepted teams. Indica’s CEO Steven Hashagen remarked “Our team is...

Indica Labs opens office in Tokyo to provide dedicated support to customers in Japan インディカ・ラボ社 国内拠点新設について

Tokyo, 9 January, 2017 – Indica Labs expanded its international presence again this month with the establishment of a new office in Tokyo, Japan and the recruitment of Hideya Makino to manage Japanese operations.  Mr. Makino has over 14 years of combined experience in the fields of microscopy, digital pathology and image analysis gained through his previous positions at Roche, Leica, Aperio, and Roper Technologies. Indica Labs’ has been steadily growing its global business since 2012.  In addition to Tokyo, Indica Labs...

Indica Labs advance immuno-oncology capabilities with innovative quantification of multiplexed chromogenic immunohistochemistry

Corrales, NM – 2 November, 2016 – Indica Labs, a leading provider of software for quantitative evaluation of digital pathology images, is pleased to announce the release of a new module for multiplex chromogenic IHC analysis using HALO™.  The Multiplex IHC module can separate up to five stains simultaneously and analyze any subcellular compartment, nucleus, cytoplasm or membrane, making it ideally suited for applications in immuno-oncology where multiple markers are required to characterize distinct immune and tumor cell populations within...

Indica Labs announce release of HALO 2.0

Corrales, NM – 11 April, 2016 – Indica Labs, a leading provider of software for quantitative evaluation of digital pathology images, is pleased to announce the latest release of its flagship image analysis platform, HALOTM.  Established as the industry’s fastest and most user-friendly analysis platform, HALO 2.0 adds new capabilities, support for new file formats, and even greater ease-of-use. Those familiar with HALO will recognize the new, more modern look-and-feel of HALO 2.0 including interchangeable dark and light skins designed to...

Boehringer Ingelheim Principal Scientist Alex Klimowicz and Indica Labs CSO Kate Lillard to present at Pathology Visions Boston

  Discoveries from the field:  Expediting drug developments and clinical trials with digital pathology and HALO image analysis Alex Klimowicz, PhD, Principal Scientist, Boehringer Ingelheim Pharmaceuticals Kate Lillard Tunstall, PhD, CSO, Indica Labs   In this 60-minute presentation, our speakers will detail how the HALO image analysis platform has been used to analyze biomarkers in translational research and drug development, respectively. So please join us October Tuesday 13th at 8 a.m. in the Carlton Ballroom at the Westin Waterfront Hotel, at the Pathology Visions Conference....